InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Bate Kenneth, 董事. Director active across 3 companies, notably Epizyme, Inc.. Aggregated, 12 filings have been logged. Activity tracked since 11 June 2021. The latest transaction was filed on 5 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Bate Kenneth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
5,470 股@ US$9.454.9% 占其流量Common StockSEC:0001628280-25-050668:0
10,000 股@ US$16.4616.3% 占其流量Common StockSEC:0001210238-25-000005:0
715 股0Common StockSEC:0001628280-25-032863:0
6,000 股@ US$111.0687.8% 占其流量Common StockSEC:0001628280-25-009076:0
714 股0Common StockSEC:0000950170-24-078754:0
10,000 股@ US$9.4512.2% 占其流量Common StockSEC:0000899243-24-000245:0
1,198 股0Common StockSEC:0000899243-23-016056:0
375 股@ US$15.00100.0% 占其流量Common StockSEC:0000899243-23-002195:0
8,060 股Common Stock, par value $0.0001SEC:0000899243-22-028858:0
8,994 股Common Stock, par value $0.0001SEC:0000899243-22-028858:1
8,994 股0Common Stock, par value $0.0001SEC:0000899243-22-018843:0
8,060 股0Common Stock, par value $0.0001SEC:0000899243-21-023878:0
12 条申报中的 12 条
About Bate Kenneth
BATE KENNETH is an Administrateur and has 12 filings in total. In the 12 sampled filings, sell transactions total EUR 5,209, the filings run from 2021-06-15 to 2025-11-07, and the main filings concern Madrigal Pharmaceuticals, INC. and Aveo Pharmaceuticals, INC.
